Generex Oral-lyn: Phase II data

In a Phase II trial of 15 patients with impaired glucose tolerance (IGT), 12 puffs of Generex Oral-lyn buccal spray significantly decreased mean plasma glucose by 31.2% at 2 hours, 28.4% at 3 hours an...